Full-Time

Trading Systems Business Associate

Trading, Multiple Teams

Posted on 8/15/2025

Weiss Asset Management

Weiss Asset Management

51-200 employees

Value-based investment firm managing $2.7B

No salary listed

Boston, MA, USA

In Person

5 days in office role in our Boston, MA office.

Category
Quantitative Finance (1)
Requirements
  • 3-5 years of experience working with order management systems (OMS)
  • Strong written and verbal communication skills
  • Comfortable working through ambiguity
Responsibilities
  • Support traders and PMs by triaging and resolving day‑to‑day issues in FlexTrade
  • Execute comprehensive testing plans during FlexTrade releases and track issue resolution
  • Identify and implement infrastructure improvements to enhance system reliability and reduce support volume
  • Test new broker connections and third‑party integrations before production rollout
  • Help evaluate new FlexTrade features and prepare summaries or demos for the trading team
  • Maintain testing environments and support configuration changes with minimal disruption to trading
  • Gather and write requirements for new workflows or system features in collaboration with traders and the senior systems lead
Desired Qualifications
  • Familiarity with SQL
Weiss Asset Management

Weiss Asset Management

View

Weiss Asset Management manages about $2.7 billion across hedge funds and institutional accounts, using proprietary, value-based investment strategies to deliver high risk-adjusted returns for clients such as foundations, pension plans, endowments, hospitals, and government entities. The firm combines deep fundamental research, statistical analysis, and rigorous decision-making to identify undervalued assets. It differentiates itself through a collaborative problem-solving culture, a long 30-year track record, and a disciplined, rational approach guided by integrity, creativity, and continuous learning. The goal is to grow and protect client wealth by applying disciplined value investing and ongoing improvement in methods.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

1991

Simplify Jobs

Simplify's Take

What believers are saying

  • AUM grew to $4.35 billion, up 61% from reported $2.7 billion.
  • Portfolio diversified across tech, mining, food, and paper industries with 561 holdings.
  • Expansion into biotech via $45 million Rokit Healthcare Series funding round.

What critics are saying

  • Rokit Healthcare biotech investment faces 50-70% failure probability within 24 months.
  • D.E. Shaw outperforms value strategies by 15% annually, triggering $1B+ AUM outflows.
  • Founder departure amid culture clashes dissolves collaborative research engine and strategy execution.

What makes Weiss Asset Management unique

  • Proprietary value-based strategies with 35-year track record since 1991.
  • Deep fundamental research and statistical analysis identify undervalued assets globally.
  • Culture emphasizes integrity, rationality, creativity, and continuous learning over individuals.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Professional Development Budget

Company News

이데일리
Mar 10th, 2026
Rokit Healthcare raises $45M from global investors including Weiss Asset Management

Rokit Healthcare has raised 62.5 billion won (approximately $45 million) in a Series funding round, with foreign capital accounting for 72% of the total investment. Leading investors include Weiss Asset Management (30 billion won), Oasis Management (7 billion won), Pacific Alliance Group (5 billion won), and LMR (3 billion won). Domestic investors, including NH Investment & Securities, Asem, Anda, GVA, and Milestone Asset Management, contributed 17.5 billion won. The investment, structured as redeemable convertible preferred shares with a one-year lock-up period, aims to minimise short-term share price volatility. The South Korean biotech and regenerative medicine company said the funding marks a turning point in its journey towards becoming a global leader in the sector.

Business Wire
Dec 20th, 2025
Orum Therapeutics Secures Approximately US$100 Million to Accelerate Development of Leading Degrader Antibody Conjugate Programs to Treat Serious Diseases

Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today ...

ETF Daily News
Jan 13th, 2025
Weiss Asset Management LP Makes New Investment in Amazon.com, Inc. (NASDAQ:AMZN)

Weiss Asset Management LP makes new Investment in Amazon.com, Inc. (NASDAQ:AMZN).

MarketBeat
Dec 10th, 2024
Weiss Asset Management LP Invests $512,000 in DICK'S Sporting Goods, Inc. (NYSE:DKS)

Weiss Asset Management LP invests $512,000 in DICK'S Sporting Goods, Inc. (NYSE:DKS).

MarketBeat
Dec 9th, 2024
Weiss Asset Management LP Makes New $1.18 Million Investment in Compass Minerals International, Inc. (NYSE:CMP)

Weiss Asset Management LP makes new $1.18 million investment in Compass Minerals International, Inc. (NYSE:CMP).

INACTIVE